ZAMBA

Zambon is a global pharmaceutical company headquartered in Italy, specializing in the development and commercialization of treatments for respiratory diseases, pain management, and central nervous system disorders. The company is well-known for its long-standing presence in the respiratory market with products like Fluimucil (acetylcysteine) and its expansion into specialty care for Parkinson's disease with Xadago (safinamide). Zambon operates with a strong focus on innovation through its Open Accelerator program and strategic partnerships to address unmet medical needs in chronic and rare diseases. With a presence in over 80 countries, the company maintains integrated manufacturing and R&D capabilities to support its diverse portfolio of established brands and specialty medicines.